# DE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION: SINGLE-CENTER RETROSPECTIVE STUDY

> **NCT06425497** · — · COMPLETED · sponsor: **University of Rome Tor Vergata** · enrollment: 600 (actual)

## Conditions studied

- Kidney Transplant; Complications
- Immunosuppression

## Interventions

- **OTHER:** The dosage of dnDSA

## Key facts

- **NCT ID:** NCT06425497
- **Lead sponsor:** University of Rome Tor Vergata
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2024-05-06
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06425497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06425497, "DE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION: SINGLE-CENTER RETROSPECTIVE STUDY". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06425497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*